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The Food Safety of Transgenic Animals'
In the last 40 years a number of modern techniques for improving animal lines have been developed. Artificial insemination has already had an enor-
mous impact on the dairy industry. Techniques such as in vitro fertilization, 
embryo cloning, nuclear transplantation and transgenesis are reaching matu-
rity. These techniques and their potential effects on the environment, genetic 
diversity, animal production and society have been discussed by George 
Seidel (1989; 1991).
Introducing food products into the market place requires that the safety 
aspect be fully analyzed and documented so that healthy transgenic animals 
will be at least as safe as the traditional animals from which they were derived.
The classical breeding of familiar food animals has been practiced since 
antiquity and has never resulted in a hereditary trait that made animals un-
safe as food. Traditional breeding is accomplished by focusing on a desirable 
trait, such as milk production or fat content, and breeding only those ani-
mals which best exemplify the trait. If the trait is quantitative, this practice 
moves the population mean in the desired direction. The cause of the impro-
vement is unknown. Theprogeny results from thousands of selections be-
tween paternal and maternal genes and the genes responsible for the im-
provement in the phenotype are rarely, if ever, identified. There is little know-
ledge of the physiological mechanism underlying the phenotypic change. Yet, 
this approach has been safe and successful and is exemplified by the dairy 
industry where selecting semen from bulls with high-producing daughters 
more than doubled the milk output per cow in the twenty years following 
1955. The genetic events associated with traditional breeding are safe; conse-
quently, only the unique features of transgenesis are examined here.
One can organize the unique features of transgenesis into three catego-
ries: the genetic construct (i.e., the DNA introduced), changes resulting 
from the integration of the construct, and the nature of the gene product.
The views expressed are not necessarily those of the Food and Drug Administration.
SAFETY CONSIDERATIONS ASSOCIATED WITH 
THE GENETIC CONSTRUCT
There is little concern about the safety of orally consumed genes. The human 
diet, consisting of bacterial, animal and plant products, include all of the ge-
netic material of those organisms. Digestive enzymes in the human gastro-
intestinal tract degrade DNA in the food and, since a single nick in a gene is 
enough to inactive the production of the gene product, the probability of a 
functional gene sequence surviving intestinal digestion may be considered 
near zero. On the off chance that some DNA does survive, it would only be 
excreted.
The increased purine and pyrimidine content of tissues resulting from 
the extra gene in transgenic animals will be negligible relative to the total tis-
sue purine content. In mammals, the purine from a single gene is on the or-
der of one millionth of the total genomic content of purines. Some plant 
breeds produced by traditional methods have resulted in large percentage in-
creases in the nucleic acid content, i.e., increases in the somatic cell chromo-
some number. These considerations may be more important if the food 
product were a sole source of protein or energy.
The DNA of the construct is of concern only if it is infectious, i.e., if it 
can be propagated in the environment or transmitted by the food to suscep-
tible cells in the gastrointestinal tract. Retroviruses are used to introduce 
genes into some species, particularly poultry. The viruses that come in con-
tact with prospective transgene recipients are defective, likely carrying at 
least one deletion in a transacting gene. Rarely, through recombination with 
endogenous viruses or from functional retroviruses present in nature, could 
fully functional viruses emerge from the helper cell line. The probability of 
functional recombinants arising is small, but they have been observed. New 
helper cell lines with less homology between the defective viruses and the 
provirus will reduce the possibility of recombinant virus production (Miller, 
1990; Temin, 1989). From the food safety perspective, even competent ani-
mal retroviruses pose no threat to human health because of the species speci-
ficity of viral infection.
SAFETY CONSIDERATIONS ASSOCIATED WITH INTEGRATION 
OF THE CONSTRUCT
The insertion of a transgene into a recipient genome is a safety consideration 
because the location and manner of insertion may increase or decrease the 
expression of host genes. The hypothesis is that the insertion process might 
activate latent toxin genes or increase levels of hormones or other substances 
detrimental to human health when the food is eaten. In healthy animals this 
is not a realistic concern. If the transgenic animal is not healthy, the cause 
must be investigated to be certain that the pathology has not resulted from 
something transmissible in the food. However, the possibility of activating a 
toxin gene is insignificant, as discussed below.
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The genetic events causing the modulation of gene expression as a result 
of transgene insertion are not different from genetic events that occur natu-
rally. Modifications of gene expression are caused by the generation of new 
connections between sequences that are not normally juxtaposed or by the 
separation of normally connected sequences. Chromosomal translocations, 
deletions and inversions occur continually in animals in nature as well as in 
food animals. Animals also contain interspersed sequences that transpose to 
new chromosomal locations, though the frequencies of transposition in food 
animals are not known. Written records of animal breeding go back as far as 
Aristotle (Sturtevant, 1965), and animal breeding has never been associated 
with the production of toxic lines of animals. This historical record is strong 
evidence for the food safety of translocations, inversions, deletions and in-
sertions in animal chromosomes.
Toxin genes are rare in animals. Animals are generally safe as food. The 
dangers in eating animal products usually stem from parasites or microbio-
logical contaminants; these are inactivated by cooking. The overwhelming 
majority of animal species can be eaten without harm. There have been re-
ports of dogs being poisoned by eating polar bear liver, but the poisonings 
are caused by high levels of vitamin A in the livers (Russel, 1966). Although 
this is an example of toxicity from the ingestion of animal tissues, the accu-
mulations of high levels of vitamin A in the liver is a complex trait and is not 
induced by a single genetic event. The genomes of the common food animals 
do not carry toxin genes that can be activated.
A classical case of acute “animal” poisoning is the biblical case of quail 
poisoning (brought to my attention by John Kirschman) described in Num-
bers, Chapter 11. During the Exodus the Israelites became tired of eating 
manna and wanted “flesh.”
And there went forth a wind from the Lord, and brought across 
quails from the sea...and the people gathered quail; he that gathered 
the least gathered ten heaps...While the flesh was yet between their 
teeth, ere it was chewed, the anger of the Lord was kindled against 
the people, and the Lord smote the people with a very great plague.
And...they buried the people that lusted.
The investigation of modern cases of quail poisoning have been attributed to 
coniine, the hemlock neurotoxin that killed Socrates. The quail feed on hem-
lock during their migration from Africa to Europe, are resistant to the toxin, 
and are able to consume enough hemlock to poison predators. The toxin it-
self is a plant product, not an animal product.
An important consideration in animals is that toxic genetic effects with 
adverse human health effects, unexpected or otherwise, are likely to produce 
visible signs in the development or growth of the transgenic animal. Trans-
genic animals are themselves an important demonstration of their food safety. 
The fact that an animal has gone through normal intrauterine development,
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birth and growth in the presence of the transgene and its product is a strong 
indication of the safety of the derived food. For the food to be toxic, the ani-
mal would have to produce a species-specific toxin that is inactive in the spe-
cies of origin, but orally active in the species consuming the food. No such 
toxins from land food-animals have been described.
THE SAFETY OF THE GENE PRODUCT
The essence of the safety review of transgenic animals must be an examina-
tion of the gene product. The safety of gene products may be reviewed in the 
same way the safety of drugs or pesticides are classically reviewed, i.e., the 
important food safety matter is the presence of a pharmacologically or toxi- 
cologically active residue. Because the product of the transgene is completely 
characterized, one can use traditional methods to evaluate its safety. This is 
an advantage over traditional breeding because the knowledge of the exact 
genetic change directs the safety inquiry to the correct gene product and its 
effects. Traditional breeding is accomplished empirically by focusing on a de-
sirable trait with little knowledge of the physiological mechanism underlying 
the phenotypic change.
Gene products may have both direct effects resulting from the action of 
the gene products themselves and indirect, secondary or compensatory ef-
fects brought about in response to the direct effects of the gene product. For 
example, somatotropin stimulates the secretion of IGF-1 from the liver and 
other tissues. IGF-1 is responsible for many of the effects formerly attributed 
directly to growth hormone and this was taken into account in evaluating the 
safety of milk from bovine somatotropin-treated cows (Juskevich and Guyer, 
1990). Such reasoning is normally part of the review of the food safety of feed 
additives and new animal drugs. Routine toxicology testing is designed to de-
tect all effects of a compound, direct and indirect.
Once the safety of the transgene product is established, transgenic ani-
mals may be considered as safe as traditional animals. Some of the food 
safety considerations may change as the technology advances. Richa and Lo 
(1989) produced “transomic” mice by introducing chromosome fragments 
dissected from metaphase spreads into fertilized ova. Chromosome frag-
ments known to be associated with desired traits can be used selectively.
Large numbers of genes (10 megabases) are introduced rather than selected 
genes. For intraspecies transfers, the results are likely to be similar to natu-
rally-occurring cases of trisomy. Transomic animals are likely to be safe also, 
but too few have been studied to make conclusions about the food safety con-
siderations.
If we imagine that we are many years in the future when livestock are 
routinely improved by recombinant DNA techniques, traditional breeding, 
in retrospect, will seem far too hazardous. To allow all the genetic changes to 
occur by chance and then never know what genes or genetic changes were re-
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sponsible for the new phenotypes is likely to seem far more risky than 
transgenesis. Cattle have 30 pairs of chromosomes. Thus, in the absence of re-
combination, a single mating has a potential of producing 2^® or 1.07 billion 
genetically different eggs or sperm. Surely the introduction of a single well- 
characterized known gene is less risky!
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